nodes	percent_of_prediction	percent_of_DWPC	metapath
Risedronate—Paget's disease of bone—ankylosing spondylitis	0.378	0.522	CtDrD
Risedronate—osteoporosis—ankylosing spondylitis	0.346	0.478	CtDrD
Risedronate—PTGS2—Sulfasalazine—ankylosing spondylitis	0.0685	0.298	CbGbCtD
Risedronate—PTGS2—Triamcinolone—ankylosing spondylitis	0.0685	0.298	CbGbCtD
Risedronate—PTGS2—Betamethasone—ankylosing spondylitis	0.0588	0.256	CbGbCtD
Risedronate—PTGS2—Dexamethasone—ankylosing spondylitis	0.0342	0.149	CbGbCtD
Risedronate—PTGS2—Fluocinonide—Methylprednisolone—ankylosing spondylitis	0.000373	0.159	CbGdCrCtD
Risedronate—PTGS2—Fluocinonide—Dexamethasone—ankylosing spondylitis	0.000367	0.156	CbGdCrCtD
Risedronate—PTGS2—Fluocinonide—Betamethasone—ankylosing spondylitis	0.000367	0.156	CbGdCrCtD
Risedronate—PTGS2—Fluocinonide—Triamcinolone—ankylosing spondylitis	0.000358	0.153	CbGdCrCtD
Risedronate—PTGS2—skeletal joint—ankylosing spondylitis	0.000227	0.351	CbGeAlD
Risedronate—PTGS2—Fluticasone Propionate—Methylprednisolone—ankylosing spondylitis	0.000225	0.0958	CbGdCrCtD
Risedronate—PTGS2—Fluticasone Propionate—Dexamethasone—ankylosing spondylitis	0.000221	0.0943	CbGdCrCtD
Risedronate—PTGS2—Fluticasone Propionate—Betamethasone—ankylosing spondylitis	0.000221	0.0943	CbGdCrCtD
Risedronate—PTGS2—Fluticasone Propionate—Triamcinolone—ankylosing spondylitis	0.000216	0.0921	CbGdCrCtD
Risedronate—PTGS2—synovial membrane of synovial joint—ankylosing spondylitis	0.000172	0.267	CbGeAlD
Risedronate—PTGS2—cartilage tissue—ankylosing spondylitis	0.000152	0.236	CbGeAlD
Risedronate—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.000107	0.00245	CcSEcCtD
Risedronate—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.000106	0.00244	CcSEcCtD
Risedronate—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.000106	0.00244	CcSEcCtD
Risedronate—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.000106	0.00242	CcSEcCtD
Risedronate—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.000105	0.00241	CcSEcCtD
Risedronate—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.000104	0.00239	CcSEcCtD
Risedronate—Depression—Prednisone—ankylosing spondylitis	0.000104	0.00238	CcSEcCtD
Risedronate—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.000103	0.00237	CcSEcCtD
Risedronate—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.000103	0.00235	CcSEcCtD
Risedronate—Angioedema—Prednisolone—ankylosing spondylitis	0.000102	0.00234	CcSEcCtD
Risedronate—Breast disorder—Methotrexate—ankylosing spondylitis	0.000102	0.00234	CcSEcCtD
Risedronate—Vertigo—Prednisolone—ankylosing spondylitis	0.0001	0.0023	CcSEcCtD
Risedronate—Syncope—Prednisolone—ankylosing spondylitis	0.0001	0.0023	CcSEcCtD
Risedronate—Eye disorder—Dexamethasone—ankylosing spondylitis	0.0001	0.0023	CcSEcCtD
Risedronate—Eye disorder—Betamethasone—ankylosing spondylitis	0.0001	0.0023	CcSEcCtD
Risedronate—Back pain—Triamcinolone—ankylosing spondylitis	9.95e-05	0.00228	CcSEcCtD
Risedronate—Loss of consciousness—Prednisolone—ankylosing spondylitis	9.83e-05	0.00225	CcSEcCtD
Risedronate—Asthma—Methotrexate—ankylosing spondylitis	9.75e-05	0.00224	CcSEcCtD
Risedronate—Angiopathy—Betamethasone—ankylosing spondylitis	9.73e-05	0.00223	CcSEcCtD
Risedronate—Angiopathy—Dexamethasone—ankylosing spondylitis	9.73e-05	0.00223	CcSEcCtD
Risedronate—Hypertension—Prednisolone—ankylosing spondylitis	9.66e-05	0.00221	CcSEcCtD
Risedronate—Arrhythmia—Dexamethasone—ankylosing spondylitis	9.58e-05	0.0022	CcSEcCtD
Risedronate—Arrhythmia—Betamethasone—ankylosing spondylitis	9.58e-05	0.0022	CcSEcCtD
Risedronate—Angioedema—Triamcinolone—ankylosing spondylitis	9.4e-05	0.00215	CcSEcCtD
Risedronate—Haemoglobin—Prednisone—ankylosing spondylitis	9.38e-05	0.00215	CcSEcCtD
Risedronate—Angioedema—Methylprednisolone—ankylosing spondylitis	9.38e-05	0.00215	CcSEcCtD
Risedronate—Abdominal discomfort—Methotrexate—ankylosing spondylitis	9.35e-05	0.00214	CcSEcCtD
Risedronate—Haemorrhage—Prednisone—ankylosing spondylitis	9.34e-05	0.00214	CcSEcCtD
Risedronate—Vertigo—Triamcinolone—ankylosing spondylitis	9.24e-05	0.00212	CcSEcCtD
Risedronate—Syncope—Triamcinolone—ankylosing spondylitis	9.22e-05	0.00211	CcSEcCtD
Risedronate—Vertigo—Methylprednisolone—ankylosing spondylitis	9.22e-05	0.00211	CcSEcCtD
Risedronate—Syncope—Methylprednisolone—ankylosing spondylitis	9.2e-05	0.00211	CcSEcCtD
Risedronate—Connective tissue disorder—Prednisone—ankylosing spondylitis	9.18e-05	0.0021	CcSEcCtD
Risedronate—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	9.06e-05	0.00208	CcSEcCtD
Risedronate—Loss of consciousness—Triamcinolone—ankylosing spondylitis	9.04e-05	0.00207	CcSEcCtD
Risedronate—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	9.02e-05	0.00207	CcSEcCtD
Risedronate—Shock—Prednisolone—ankylosing spondylitis	8.98e-05	0.00206	CcSEcCtD
Risedronate—Cough—Triamcinolone—ankylosing spondylitis	8.98e-05	0.00206	CcSEcCtD
Risedronate—Hypertension—Triamcinolone—ankylosing spondylitis	8.88e-05	0.00204	CcSEcCtD
Risedronate—Hypertension—Methylprednisolone—ankylosing spondylitis	8.86e-05	0.00203	CcSEcCtD
Risedronate—Myalgia—Triamcinolone—ankylosing spondylitis	8.76e-05	0.00201	CcSEcCtD
Risedronate—Pneumonia—Methotrexate—ankylosing spondylitis	8.74e-05	0.002	CcSEcCtD
Risedronate—Arthralgia—Methylprednisolone—ankylosing spondylitis	8.74e-05	0.002	CcSEcCtD
Risedronate—Myalgia—Methylprednisolone—ankylosing spondylitis	8.74e-05	0.002	CcSEcCtD
Risedronate—Eye disorder—Prednisone—ankylosing spondylitis	8.73e-05	0.002	CcSEcCtD
Risedronate—Anxiety—Methylprednisolone—ankylosing spondylitis	8.71e-05	0.002	CcSEcCtD
Risedronate—Infestation NOS—Methotrexate—ankylosing spondylitis	8.69e-05	0.00199	CcSEcCtD
Risedronate—Infestation—Methotrexate—ankylosing spondylitis	8.69e-05	0.00199	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	8.68e-05	0.00199	CcSEcCtD
Risedronate—Depression—Methotrexate—ankylosing spondylitis	8.67e-05	0.00199	CcSEcCtD
Risedronate—Dry mouth—Triamcinolone—ankylosing spondylitis	8.56e-05	0.00196	CcSEcCtD
Risedronate—Angioedema—Dexamethasone—ankylosing spondylitis	8.53e-05	0.00196	CcSEcCtD
Risedronate—Angioedema—Betamethasone—ankylosing spondylitis	8.53e-05	0.00196	CcSEcCtD
Risedronate—Angiopathy—Prednisone—ankylosing spondylitis	8.47e-05	0.00194	CcSEcCtD
Risedronate—Conjunctivitis—Methotrexate—ankylosing spondylitis	8.45e-05	0.00194	CcSEcCtD
Risedronate—Immune system disorder—Prednisone—ankylosing spondylitis	8.43e-05	0.00193	CcSEcCtD
Risedronate—Vertigo—Betamethasone—ankylosing spondylitis	8.39e-05	0.00192	CcSEcCtD
Risedronate—Vertigo—Dexamethasone—ankylosing spondylitis	8.39e-05	0.00192	CcSEcCtD
Risedronate—Syncope—Betamethasone—ankylosing spondylitis	8.37e-05	0.00192	CcSEcCtD
Risedronate—Syncope—Dexamethasone—ankylosing spondylitis	8.37e-05	0.00192	CcSEcCtD
Risedronate—Arrhythmia—Prednisone—ankylosing spondylitis	8.34e-05	0.00191	CcSEcCtD
Risedronate—Infection—Triamcinolone—ankylosing spondylitis	8.34e-05	0.00191	CcSEcCtD
Risedronate—Infection—Methylprednisolone—ankylosing spondylitis	8.32e-05	0.00191	CcSEcCtD
Risedronate—Shock—Triamcinolone—ankylosing spondylitis	8.26e-05	0.00189	CcSEcCtD
Risedronate—Insomnia—Prednisolone—ankylosing spondylitis	8.26e-05	0.00189	CcSEcCtD
Risedronate—Shock—Methylprednisolone—ankylosing spondylitis	8.24e-05	0.00189	CcSEcCtD
Risedronate—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	8.22e-05	0.00188	CcSEcCtD
Risedronate—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	8.21e-05	0.00188	CcSEcCtD
Risedronate—Loss of consciousness—Betamethasone—ankylosing spondylitis	8.2e-05	0.00188	CcSEcCtD
Risedronate—Loss of consciousness—Dexamethasone—ankylosing spondylitis	8.2e-05	0.00188	CcSEcCtD
Risedronate—Paraesthesia—Prednisolone—ankylosing spondylitis	8.2e-05	0.00188	CcSEcCtD
Risedronate—Mental disorder—Prednisone—ankylosing spondylitis	8.18e-05	0.00188	CcSEcCtD
Risedronate—Skin disorder—Methylprednisolone—ankylosing spondylitis	8.14e-05	0.00187	CcSEcCtD
Risedronate—Malnutrition—Prednisone—ankylosing spondylitis	8.13e-05	0.00186	CcSEcCtD
Risedronate—Hypertension—Dexamethasone—ankylosing spondylitis	8.06e-05	0.00185	CcSEcCtD
Risedronate—Hypertension—Betamethasone—ankylosing spondylitis	8.06e-05	0.00185	CcSEcCtD
Risedronate—Myalgia—Dexamethasone—ankylosing spondylitis	7.95e-05	0.00182	CcSEcCtD
Risedronate—Myalgia—Betamethasone—ankylosing spondylitis	7.95e-05	0.00182	CcSEcCtD
Risedronate—Anxiety—Betamethasone—ankylosing spondylitis	7.92e-05	0.00182	CcSEcCtD
Risedronate—Anxiety—Dexamethasone—ankylosing spondylitis	7.92e-05	0.00182	CcSEcCtD
Risedronate—Haemoglobin—Methotrexate—ankylosing spondylitis	7.84e-05	0.0018	CcSEcCtD
Risedronate—Pain—Prednisolone—ankylosing spondylitis	7.81e-05	0.00179	CcSEcCtD
Risedronate—Haemorrhage—Methotrexate—ankylosing spondylitis	7.8e-05	0.00179	CcSEcCtD
Risedronate—Pharyngitis—Methotrexate—ankylosing spondylitis	7.74e-05	0.00178	CcSEcCtD
Risedronate—Urinary tract disorder—Methotrexate—ankylosing spondylitis	7.71e-05	0.00177	CcSEcCtD
Risedronate—Urethral disorder—Methotrexate—ankylosing spondylitis	7.65e-05	0.00175	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	7.65e-05	0.00175	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	7.63e-05	0.00175	CcSEcCtD
Risedronate—Insomnia—Triamcinolone—ankylosing spondylitis	7.59e-05	0.00174	CcSEcCtD
Risedronate—Insomnia—Methylprednisolone—ankylosing spondylitis	7.58e-05	0.00174	CcSEcCtD
Risedronate—Infection—Dexamethasone—ankylosing spondylitis	7.57e-05	0.00173	CcSEcCtD
Risedronate—Infection—Betamethasone—ankylosing spondylitis	7.57e-05	0.00173	CcSEcCtD
Risedronate—Paraesthesia—Triamcinolone—ankylosing spondylitis	7.54e-05	0.00173	CcSEcCtD
Risedronate—Paraesthesia—Methylprednisolone—ankylosing spondylitis	7.52e-05	0.00172	CcSEcCtD
Risedronate—Anaemia—Prednisone—ankylosing spondylitis	7.51e-05	0.00172	CcSEcCtD
Risedronate—Shock—Betamethasone—ankylosing spondylitis	7.49e-05	0.00172	CcSEcCtD
Risedronate—Shock—Dexamethasone—ankylosing spondylitis	7.49e-05	0.00172	CcSEcCtD
Risedronate—Dyspnoea—Triamcinolone—ankylosing spondylitis	7.48e-05	0.00172	CcSEcCtD
Risedronate—Nervous system disorder—Dexamethasone—ankylosing spondylitis	7.47e-05	0.00171	CcSEcCtD
Risedronate—Nervous system disorder—Betamethasone—ankylosing spondylitis	7.47e-05	0.00171	CcSEcCtD
Risedronate—Angioedema—Prednisone—ankylosing spondylitis	7.43e-05	0.0017	CcSEcCtD
Risedronate—Dyspepsia—Triamcinolone—ankylosing spondylitis	7.39e-05	0.00169	CcSEcCtD
Risedronate—Dyspepsia—Methylprednisolone—ankylosing spondylitis	7.37e-05	0.00169	CcSEcCtD
Risedronate—Vertigo—Prednisone—ankylosing spondylitis	7.3e-05	0.00167	CcSEcCtD
Risedronate—Eye disorder—Methotrexate—ankylosing spondylitis	7.29e-05	0.00167	CcSEcCtD
Risedronate—Syncope—Prednisone—ankylosing spondylitis	7.29e-05	0.00167	CcSEcCtD
Risedronate—Tinnitus—Methotrexate—ankylosing spondylitis	7.28e-05	0.00167	CcSEcCtD
Risedronate—Urticaria—Prednisolone—ankylosing spondylitis	7.25e-05	0.00166	CcSEcCtD
Risedronate—Cardiac disorder—Methotrexate—ankylosing spondylitis	7.24e-05	0.00166	CcSEcCtD
Risedronate—Fatigue—Triamcinolone—ankylosing spondylitis	7.24e-05	0.00166	CcSEcCtD
Risedronate—Fatigue—Methylprednisolone—ankylosing spondylitis	7.22e-05	0.00166	CcSEcCtD
Risedronate—Pain—Triamcinolone—ankylosing spondylitis	7.18e-05	0.00165	CcSEcCtD
Risedronate—Loss of consciousness—Prednisone—ankylosing spondylitis	7.14e-05	0.00164	CcSEcCtD
Risedronate—Angiopathy—Methotrexate—ankylosing spondylitis	7.08e-05	0.00162	CcSEcCtD
Risedronate—Immune system disorder—Methotrexate—ankylosing spondylitis	7.05e-05	0.00162	CcSEcCtD
Risedronate—Mediastinal disorder—Methotrexate—ankylosing spondylitis	7.03e-05	0.00161	CcSEcCtD
Risedronate—Hypertension—Prednisone—ankylosing spondylitis	7.02e-05	0.00161	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	6.94e-05	0.00159	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	6.94e-05	0.00159	CcSEcCtD
Risedronate—Arthralgia—Prednisone—ankylosing spondylitis	6.92e-05	0.00159	CcSEcCtD
Risedronate—Myalgia—Prednisone—ankylosing spondylitis	6.92e-05	0.00159	CcSEcCtD
Risedronate—Anxiety—Prednisone—ankylosing spondylitis	6.9e-05	0.00158	CcSEcCtD
Risedronate—Insomnia—Betamethasone—ankylosing spondylitis	6.89e-05	0.00158	CcSEcCtD
Risedronate—Insomnia—Dexamethasone—ankylosing spondylitis	6.89e-05	0.00158	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	6.87e-05	0.00158	CcSEcCtD
Risedronate—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	6.85e-05	0.00157	CcSEcCtD
Risedronate—Paraesthesia—Dexamethasone—ankylosing spondylitis	6.84e-05	0.00157	CcSEcCtD
Risedronate—Paraesthesia—Betamethasone—ankylosing spondylitis	6.84e-05	0.00157	CcSEcCtD
Risedronate—Mental disorder—Methotrexate—ankylosing spondylitis	6.84e-05	0.00157	CcSEcCtD
Risedronate—FDPS—tendon—ankylosing spondylitis	6.8e-05	0.105	CbGeAlD
Risedronate—Malnutrition—Methotrexate—ankylosing spondylitis	6.79e-05	0.00156	CcSEcCtD
Risedronate—Hypersensitivity—Prednisolone—ankylosing spondylitis	6.73e-05	0.00154	CcSEcCtD
Risedronate—Dyspepsia—Dexamethasone—ankylosing spondylitis	6.71e-05	0.00154	CcSEcCtD
Risedronate—Dyspepsia—Betamethasone—ankylosing spondylitis	6.71e-05	0.00154	CcSEcCtD
Risedronate—Urticaria—Triamcinolone—ankylosing spondylitis	6.67e-05	0.00153	CcSEcCtD
Risedronate—Urticaria—Methylprednisolone—ankylosing spondylitis	6.65e-05	0.00153	CcSEcCtD
Risedronate—Body temperature increased—Triamcinolone—ankylosing spondylitis	6.64e-05	0.00152	CcSEcCtD
Risedronate—Abdominal pain—Methylprednisolone—ankylosing spondylitis	6.62e-05	0.00152	CcSEcCtD
Risedronate—Infection—Prednisone—ankylosing spondylitis	6.59e-05	0.00151	CcSEcCtD
Risedronate—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	6.58e-05	0.00151	CcSEcCtD
Risedronate—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	6.58e-05	0.00151	CcSEcCtD
Risedronate—Back pain—Methotrexate—ankylosing spondylitis	6.57e-05	0.00151	CcSEcCtD
Risedronate—Fatigue—Betamethasone—ankylosing spondylitis	6.57e-05	0.00151	CcSEcCtD
Risedronate—Fatigue—Dexamethasone—ankylosing spondylitis	6.57e-05	0.00151	CcSEcCtD
Risedronate—Shock—Prednisone—ankylosing spondylitis	6.53e-05	0.0015	CcSEcCtD
Risedronate—Pain—Dexamethasone—ankylosing spondylitis	6.51e-05	0.00149	CcSEcCtD
Risedronate—Pain—Betamethasone—ankylosing spondylitis	6.51e-05	0.00149	CcSEcCtD
Risedronate—Nervous system disorder—Prednisone—ankylosing spondylitis	6.51e-05	0.00149	CcSEcCtD
Risedronate—Skin disorder—Prednisone—ankylosing spondylitis	6.44e-05	0.00148	CcSEcCtD
Risedronate—Anaemia—Methotrexate—ankylosing spondylitis	6.28e-05	0.00144	CcSEcCtD
Risedronate—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	6.23e-05	0.00143	CcSEcCtD
Risedronate—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	6.23e-05	0.00143	CcSEcCtD
Risedronate—Hypersensitivity—Triamcinolone—ankylosing spondylitis	6.19e-05	0.00142	CcSEcCtD
Risedronate—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	6.17e-05	0.00141	CcSEcCtD
Risedronate—Vertigo—Methotrexate—ankylosing spondylitis	6.1e-05	0.0014	CcSEcCtD
Risedronate—Urticaria—Dexamethasone—ankylosing spondylitis	6.05e-05	0.00139	CcSEcCtD
Risedronate—Urticaria—Betamethasone—ankylosing spondylitis	6.05e-05	0.00139	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	6.04e-05	0.00139	CcSEcCtD
Risedronate—Dizziness—Prednisolone—ankylosing spondylitis	6.04e-05	0.00138	CcSEcCtD
Risedronate—Asthenia—Triamcinolone—ankylosing spondylitis	6.02e-05	0.00138	CcSEcCtD
Risedronate—Abdominal pain—Betamethasone—ankylosing spondylitis	6.02e-05	0.00138	CcSEcCtD
Risedronate—Abdominal pain—Dexamethasone—ankylosing spondylitis	6.02e-05	0.00138	CcSEcCtD
Risedronate—Body temperature increased—Betamethasone—ankylosing spondylitis	6.02e-05	0.00138	CcSEcCtD
Risedronate—Body temperature increased—Dexamethasone—ankylosing spondylitis	6.02e-05	0.00138	CcSEcCtD
Risedronate—Asthenia—Methylprednisolone—ankylosing spondylitis	6.01e-05	0.00138	CcSEcCtD
Risedronate—Insomnia—Prednisone—ankylosing spondylitis	6e-05	0.00138	CcSEcCtD
Risedronate—Paraesthesia—Prednisone—ankylosing spondylitis	5.96e-05	0.00137	CcSEcCtD
Risedronate—Pruritus—Triamcinolone—ankylosing spondylitis	5.94e-05	0.00136	CcSEcCtD
Risedronate—Cough—Methotrexate—ankylosing spondylitis	5.93e-05	0.00136	CcSEcCtD
Risedronate—Pruritus—Methylprednisolone—ankylosing spondylitis	5.93e-05	0.00136	CcSEcCtD
Risedronate—Dyspepsia—Prednisone—ankylosing spondylitis	5.84e-05	0.00134	CcSEcCtD
Risedronate—Arthralgia—Methotrexate—ankylosing spondylitis	5.78e-05	0.00133	CcSEcCtD
Risedronate—Myalgia—Methotrexate—ankylosing spondylitis	5.78e-05	0.00133	CcSEcCtD
Risedronate—Chest pain—Methotrexate—ankylosing spondylitis	5.78e-05	0.00133	CcSEcCtD
Risedronate—Rash—Prednisolone—ankylosing spondylitis	5.76e-05	0.00132	CcSEcCtD
Risedronate—Dermatitis—Prednisolone—ankylosing spondylitis	5.75e-05	0.00132	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	5.74e-05	0.00132	CcSEcCtD
Risedronate—Diarrhoea—Methylprednisolone—ankylosing spondylitis	5.73e-05	0.00131	CcSEcCtD
Risedronate—Fatigue—Prednisone—ankylosing spondylitis	5.72e-05	0.00131	CcSEcCtD
Risedronate—Headache—Prednisolone—ankylosing spondylitis	5.72e-05	0.00131	CcSEcCtD
Risedronate—Constipation—Prednisone—ankylosing spondylitis	5.67e-05	0.0013	CcSEcCtD
Risedronate—Dizziness—Triamcinolone—ankylosing spondylitis	5.55e-05	0.00127	CcSEcCtD
Risedronate—Dizziness—Methylprednisolone—ankylosing spondylitis	5.54e-05	0.00127	CcSEcCtD
Risedronate—Infection—Methotrexate—ankylosing spondylitis	5.51e-05	0.00126	CcSEcCtD
Risedronate—Asthenia—Betamethasone—ankylosing spondylitis	5.47e-05	0.00125	CcSEcCtD
Risedronate—Asthenia—Dexamethasone—ankylosing spondylitis	5.47e-05	0.00125	CcSEcCtD
Risedronate—Nervous system disorder—Methotrexate—ankylosing spondylitis	5.44e-05	0.00125	CcSEcCtD
Risedronate—Gastrointestinal pain—Prednisone—ankylosing spondylitis	5.42e-05	0.00124	CcSEcCtD
Risedronate—Nausea—Prednisolone—ankylosing spondylitis	5.42e-05	0.00124	CcSEcCtD
Risedronate—Pruritus—Dexamethasone—ankylosing spondylitis	5.39e-05	0.00124	CcSEcCtD
Risedronate—Pruritus—Betamethasone—ankylosing spondylitis	5.39e-05	0.00124	CcSEcCtD
Risedronate—Skin disorder—Methotrexate—ankylosing spondylitis	5.39e-05	0.00123	CcSEcCtD
Risedronate—Vomiting—Triamcinolone—ankylosing spondylitis	5.34e-05	0.00122	CcSEcCtD
Risedronate—Vomiting—Methylprednisolone—ankylosing spondylitis	5.33e-05	0.00122	CcSEcCtD
Risedronate—Rash—Triamcinolone—ankylosing spondylitis	5.29e-05	0.00121	CcSEcCtD
Risedronate—Dermatitis—Triamcinolone—ankylosing spondylitis	5.29e-05	0.00121	CcSEcCtD
Risedronate—Rash—Methylprednisolone—ankylosing spondylitis	5.28e-05	0.00121	CcSEcCtD
Risedronate—Dermatitis—Methylprednisolone—ankylosing spondylitis	5.28e-05	0.00121	CcSEcCtD
Risedronate—Urticaria—Prednisone—ankylosing spondylitis	5.27e-05	0.00121	CcSEcCtD
Risedronate—Headache—Triamcinolone—ankylosing spondylitis	5.26e-05	0.00121	CcSEcCtD
Risedronate—Headache—Methylprednisolone—ankylosing spondylitis	5.25e-05	0.0012	CcSEcCtD
Risedronate—Body temperature increased—Prednisone—ankylosing spondylitis	5.24e-05	0.0012	CcSEcCtD
Risedronate—Abdominal pain—Prednisone—ankylosing spondylitis	5.24e-05	0.0012	CcSEcCtD
Risedronate—Diarrhoea—Betamethasone—ankylosing spondylitis	5.21e-05	0.00119	CcSEcCtD
Risedronate—Diarrhoea—Dexamethasone—ankylosing spondylitis	5.21e-05	0.00119	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	5.05e-05	0.00116	CcSEcCtD
Risedronate—Dizziness—Dexamethasone—ankylosing spondylitis	5.04e-05	0.00115	CcSEcCtD
Risedronate—Dizziness—Betamethasone—ankylosing spondylitis	5.04e-05	0.00115	CcSEcCtD
Risedronate—Insomnia—Methotrexate—ankylosing spondylitis	5.01e-05	0.00115	CcSEcCtD
Risedronate—Nausea—Triamcinolone—ankylosing spondylitis	4.99e-05	0.00114	CcSEcCtD
Risedronate—Paraesthesia—Methotrexate—ankylosing spondylitis	4.98e-05	0.00114	CcSEcCtD
Risedronate—Nausea—Methylprednisolone—ankylosing spondylitis	4.98e-05	0.00114	CcSEcCtD
Risedronate—Dyspnoea—Methotrexate—ankylosing spondylitis	4.94e-05	0.00113	CcSEcCtD
Risedronate—Hypersensitivity—Prednisone—ankylosing spondylitis	4.89e-05	0.00112	CcSEcCtD
Risedronate—Dyspepsia—Methotrexate—ankylosing spondylitis	4.88e-05	0.00112	CcSEcCtD
Risedronate—Vomiting—Dexamethasone—ankylosing spondylitis	4.84e-05	0.00111	CcSEcCtD
Risedronate—Vomiting—Betamethasone—ankylosing spondylitis	4.84e-05	0.00111	CcSEcCtD
Risedronate—Rash—Dexamethasone—ankylosing spondylitis	4.8e-05	0.0011	CcSEcCtD
Risedronate—Rash—Betamethasone—ankylosing spondylitis	4.8e-05	0.0011	CcSEcCtD
Risedronate—Dermatitis—Betamethasone—ankylosing spondylitis	4.8e-05	0.0011	CcSEcCtD
Risedronate—Dermatitis—Dexamethasone—ankylosing spondylitis	4.8e-05	0.0011	CcSEcCtD
Risedronate—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	4.79e-05	0.0011	CcSEcCtD
Risedronate—Fatigue—Methotrexate—ankylosing spondylitis	4.78e-05	0.0011	CcSEcCtD
Risedronate—Headache—Betamethasone—ankylosing spondylitis	4.77e-05	0.00109	CcSEcCtD
Risedronate—Headache—Dexamethasone—ankylosing spondylitis	4.77e-05	0.00109	CcSEcCtD
Risedronate—Asthenia—Prednisone—ankylosing spondylitis	4.76e-05	0.00109	CcSEcCtD
Risedronate—Pain—Methotrexate—ankylosing spondylitis	4.74e-05	0.00109	CcSEcCtD
Risedronate—Pruritus—Prednisone—ankylosing spondylitis	4.69e-05	0.00108	CcSEcCtD
Risedronate—Diarrhoea—Prednisone—ankylosing spondylitis	4.54e-05	0.00104	CcSEcCtD
Risedronate—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	4.53e-05	0.00104	CcSEcCtD
Risedronate—Nausea—Betamethasone—ankylosing spondylitis	4.52e-05	0.00104	CcSEcCtD
Risedronate—Nausea—Dexamethasone—ankylosing spondylitis	4.52e-05	0.00104	CcSEcCtD
Risedronate—Urticaria—Methotrexate—ankylosing spondylitis	4.4e-05	0.00101	CcSEcCtD
Risedronate—Dizziness—Prednisone—ankylosing spondylitis	4.39e-05	0.00101	CcSEcCtD
Risedronate—Abdominal pain—Methotrexate—ankylosing spondylitis	4.38e-05	0.001	CcSEcCtD
Risedronate—Body temperature increased—Methotrexate—ankylosing spondylitis	4.38e-05	0.001	CcSEcCtD
Risedronate—Vomiting—Prednisone—ankylosing spondylitis	4.22e-05	0.000967	CcSEcCtD
Risedronate—Rash—Prednisone—ankylosing spondylitis	4.18e-05	0.000959	CcSEcCtD
Risedronate—Dermatitis—Prednisone—ankylosing spondylitis	4.18e-05	0.000958	CcSEcCtD
Risedronate—Headache—Prednisone—ankylosing spondylitis	4.16e-05	0.000953	CcSEcCtD
Risedronate—Hypersensitivity—Methotrexate—ankylosing spondylitis	4.08e-05	0.000936	CcSEcCtD
Risedronate—Asthenia—Methotrexate—ankylosing spondylitis	3.98e-05	0.000912	CcSEcCtD
Risedronate—Nausea—Prednisone—ankylosing spondylitis	3.94e-05	0.000903	CcSEcCtD
Risedronate—Pruritus—Methotrexate—ankylosing spondylitis	3.92e-05	0.000899	CcSEcCtD
Risedronate—Diarrhoea—Methotrexate—ankylosing spondylitis	3.79e-05	0.00087	CcSEcCtD
Risedronate—Dizziness—Methotrexate—ankylosing spondylitis	3.67e-05	0.000841	CcSEcCtD
Risedronate—Vomiting—Methotrexate—ankylosing spondylitis	3.53e-05	0.000808	CcSEcCtD
Risedronate—Rash—Methotrexate—ankylosing spondylitis	3.5e-05	0.000801	CcSEcCtD
Risedronate—Dermatitis—Methotrexate—ankylosing spondylitis	3.49e-05	0.000801	CcSEcCtD
Risedronate—Headache—Methotrexate—ankylosing spondylitis	3.47e-05	0.000796	CcSEcCtD
Risedronate—Nausea—Methotrexate—ankylosing spondylitis	3.29e-05	0.000755	CcSEcCtD
Risedronate—PTGS2—tendon—ankylosing spondylitis	2.6e-05	0.0404	CbGeAlD
